Literature DB >> 11686485

Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin.

C J Weegink, R A Chamuleau, H W Reesink, D S Molenaar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11686485     DOI： 10.1007/s005350170038

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  3 in total

1.  Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.

Authors:  A Oishi; K Miyamoto; S Kashii; N Yoshimura
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

2.  Management of Hepatitis C Antiviral Therapy Adverse Effects.

Authors:  Hubert Sung; Michael Chang; Sammy Saab
Journal:  Curr Hepat Rep       Date:  2010-12-24

3.  Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report.

Authors:  Su Jung Baik; Tae Hun Kim; Hye In Kim; Jeong Yeon Rhie
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.